US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Overview of attention for article published in Open Forum Infectious Diseases, December 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 31 Mendeley